Where other common chiral ligands failed, (−)-sparteine can be employed to form complexes with Grignard reagents. These chirally modified reagents desymmetrize a range of anhydrides with good enantioselectivity (up to 92 % ee; see scheme). Whereas (−)-sparteine is well known to form complexes with organolithium reagents and to induce excellent enantioselection in their reactions with electrophiles, (−)-sparteine-controlled asymmetric processes that involve Grignard reagents are rare.
No takes yet. Share an insight, caveat, or question.
Shintani et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: